Myxoid Liposarcoma
Myxoid liposarcoma is a rare type of cancer that arises in fat cells, characterized by a mix of myxoid (gel-like) and round cell components, often found in the limbs or retroperitoneum.
Long-Term Follow-Up of Adoptive Cell Therapies
We are monitoring individuals who received genetically modified cell treatments to check for any delayed side effects and how long these cells remain in the body. This study aims to ensure safety and understand the treatment's long-term effects.
>2 yearsSafety phase (I)No PlaceboPartially RemoteInvestigational MedicinesInjectionInternal MedicineOncology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Multiple Myeloma
Multiple myeloma is a cancer of the plasma cells in the bone marrow, leading to the production of abnormal proteins that can cause various health issues, including bone pain and anemia.
Synovial Sarcoma
Synovial sarcoma is a rare and aggressive soft tissue cancer that typically occurs near joints, particularly in the arms and legs, and can affect both young adults and children.
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, characterized by uncontrolled cell growth in lung tissues, often linked to smoking and environmental factors.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Have you received at least one dose of ADP adoptive cell therapy?
- Have you completed a study sponsored or supported by ADP, or have you withdrawn from it?
- Have you completed treatment as part of managed access to an adoptive cell therapy?
- Are you able to give signed informed consent for participation in this study?
- Are you using contraception that follows local regulations for clinical studies?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
GSK3377794
Letetresgene Autoleucel
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Fondazione IRCCS Istituto Nazionale Dei Tumori
Department of Medical Oncology
Milan, Italy
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Division of Medical Oncology, Division of Molecular Oncology & Immunology
Amstelveen, Netherlands
University Hospital Virgen Del Rocio S.L.
Medical Oncology Service
Huelva, Spain
Sponsor: Adaptimmune LLC
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.